Botulinum-Toxin-AIatrogenic botulism, off-label use and overdose: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72172-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：63 / 63

相关论文

共 50 条

[41] SugammadexVarious toxicities and off-label use: 21 case reports
Reactions Weekly, 2022, 1899 (1) : 349 - 349
[42] BebtelovimabAnaphylaxis following off-label use: 2 case reports
Reactions Weekly, 2023, 1954 (1) : 113 - 113
[43] PolidocanolVarious toxicities and off-label use: 34 case reports
Reactions Weekly, 2022, 1896 (1) : 393 - 393
[44] DexmedetomidineVarious toxicities and off-label use: 5 case reports
Reactions Weekly, 2023, 1954 (1) : 186 - 186
[45] RituximabVarious toxicities and off-label use: 3 case reports
Reactions Weekly, 2023, 1940 (1) : 374 - 374
[46] AntibacterialsLack of efficacy and off-label use: 10 case reports
Reactions Weekly, 2022, 1925 (1) : 48 - 48
[47] AntineoplasticsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1920 (1) : 58 - 58
[48] FerumoxytolNausea following off-label use: 2 case reports
Reactions Weekly, 2017, 1650 (1) : 142 - 142
[49] Botulinum toxin: Non cosmetic and off-label dermatological uses
Al-Ghamdi, Ali S.
Alghanemy, Noah
Joharji, Hanan
Al-Qahtani, Dhafer
Alghamdi, Hasan
JOURNAL OF DERMATOLOGY DERMATOLOGIC SURGERY-JDDS, 2015, 19 (01): : 1 - 8
[50] Emerging off-label esthetic uses of botulinum toxin in dermatology
Phan, Kevin
Younessi, Shannon
Dubin, Danielle
Lin, Matthew J.
Khorasani, Hooman
DERMATOLOGIC THERAPY, 2022, 35 (01)

← 1 2 3 4 5 →